Ling Xu
About
Ling Xu has authored 127 papers that have received a total of 2.1k indexed citations.
This includes 59 papers in Cancer Research, 57 papers in Oncology and 29 papers in Molecular Biology. The topics of these papers are Breast Cancer Treatment Studies (41 papers), HER2/EGFR in Cancer Research (31 papers) and MicroRNA in disease regulation (14 papers). Ling Xu is often cited by papers focused on Breast Cancer Treatment Studies (41 papers), HER2/EGFR in Cancer Research (31 papers) and MicroRNA in disease regulation (14 papers) and collaborates with scholars based in China, Australia and United States. Ling Xu's co-authors include Jingming Ye, Shi‐Ting Feng, Xuening Duan, Yinhua Liu and Zi-Ping Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.
In The Last Decade
Fields of papers published by Ling Xu
Since SpecializationEngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics
Countries citing papers authored by Ling Xu
Since SpecializationCitations
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Sanjay Gupta Breakdown of academic impact, for papers by Tetsuya Tsukahara Breakdown of academic impact, for papers by Antonella Tufano Breakdown of academic impact, for papers by Ali S. Abdelhameed Breakdown of academic impact, for papers by Bijan Das Breakdown of academic impact, for papers by Takuya Nomoto Breakdown of academic impact, for papers by Seema Sood Breakdown of academic impact, for papers by Jian Xiao